Beyond the Michaelis-Menten: Accurate Prediction of In Vivo Hepatic Clearance for Drugs With Low K


Journal

Clinical and translational science
ISSN: 1752-8062
Titre abrégé: Clin Transl Sci
Pays: United States
ID NLM: 101474067

Informations de publication

Date de publication:
11 2020
Historique:
received: 18 10 2019
accepted: 12 04 2020
pubmed: 24 4 2020
medline: 16 10 2021
entrez: 24 4 2020
Statut: ppublish

Résumé

Clearance (CL) is the major pharmacokinetic parameter for evaluating systemic exposure of drugs in the body and, thus, for developing new drugs. To predict in vivo CL, the ratio between the maximal rate of metabolism and Michaelis-Menten constant (V

Identifiants

pubmed: 32324332
doi: 10.1111/cts.12804
pmc: PMC7719389
doi:

Substances chimiques

Coumarins 0
Propafenone 68IQX3T69U
Cytochrome P-450 Enzyme System 9035-51-2
coumarin A4VZ22K1WT
Paclitaxel P88XT4IS4D
Midazolam R60L0SM5BC

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1199-1207

Informations de copyright

© 2020 The Authors. Clinical and Translational Science published by Wiley Periodicals LLC on behalf of the American Society for Clinical Pharmacology and Therapeutics.

Références

Drug Metab Dispos. 2012 Jan;40(1):83-92
pubmed: 21994437
Drug Metab Dispos. 2000 Mar;28(3):246-54
pubmed: 10681367
Clin Pharmacol Ther. 1992 Nov;52(5):453-7
pubmed: 1424418
FEBS J. 2014 Jan;281(2):464-72
pubmed: 24245583
Pharm Res. 2015 Mar;32(3):1141-57
pubmed: 25288013
CPT Pharmacometrics Syst Pharmacol. 2014 Aug 13;3:e130
pubmed: 25116274
Eur J Med Res. 2011 Apr 28;16(4):139-44
pubmed: 21486727
J Pharm Biomed Anal. 2014 Nov;100:393-401
pubmed: 25218440
J Pharm Sci. 2016 Feb;105(2):846-853
pubmed: 26202434
Pharm Res. 2004 May;21(5):785-92
pubmed: 15180335
Biosci Rep. 2017 Nov 21;37(6):
pubmed: 29054967
Antimicrob Agents Chemother. 2009 Feb;53(2):541-51
pubmed: 19029318
Drug Metab Dispos. 2002 Dec;30(12):1441-5
pubmed: 12433817
Basic Clin Pharmacol Toxicol. 2015 Aug;117(2):117-25
pubmed: 25536375
Bull Math Biol. 2003 Nov;65(6):1111-29
pubmed: 14607291
J Pharmacol Exp Ther. 1977 Feb;200(2):420-4
pubmed: 839445
Sci Rep. 2017 Dec 5;7(1):17018
pubmed: 29208922
Drug Metab Dispos. 2005 Sep;33(9):1304-11
pubmed: 15932954
Nat Rev Drug Discov. 2007 Feb;6(2):140-8
pubmed: 17268485
Pharm Res. 1993 Jul;10(7):1093-5
pubmed: 8378254
Rev Infect Dis. 1990 Mar-Apr;12 Suppl 3:S318-26
pubmed: 2184510
Drug Metab Dispos. 2003 Apr;31(4):421-31
pubmed: 12642468
Pharm Res. 2005 Jan;22(1):103-12
pubmed: 15771236
Drug Metab Dispos. 2002 Jul;30(7):831-7
pubmed: 12065442
Curr Top Med Chem. 2011;11(4):334-9
pubmed: 21320062
Pharm Res. 2010 Oct;27(10):2150-61
pubmed: 20661765
J Biol Chem. 1970 Sep 25;245(18):4814-8
pubmed: 5456154
IET Syst Biol. 2016 Aug;10(4):125-35
pubmed: 27444022
Xenobiotica. 2006 Jun;36(6):473-97
pubmed: 16769646
Proc Natl Acad Sci U S A. 2005 Oct 11;102(41):14617-22
pubmed: 16195377
Drug Metab Dispos. 1999 Aug;27(8):902-8
pubmed: 10421617
Drug Metab Dispos. 1999 Nov;27(11):1350-9
pubmed: 10534321
Curr Drug Metab. 2007 Jan;8(1):33-45
pubmed: 17266522
Mol Pharmacol. 1988 May;33(5):493-9
pubmed: 3367901
Antimicrob Agents Chemother. 2011 Feb;55(2):925-8
pubmed: 21078931
J Pharm Sci. 2011 Jan;100(1):341-52
pubmed: 20564338
Pharmacol Ther. 1997;73(2):147-71
pubmed: 9131722
Drug Metab Dispos. 2007 Feb;35(2):293-301
pubmed: 17132764
Clin Pharmacol Ther. 2018 Mar;103(3):521-525
pubmed: 28762489
Clin Pharmacol Ther. 2008 Jan;83(1):77-85
pubmed: 17495874
Ann ICRP. 2009;39(2):1-164
pubmed: 19897132
Drug Metab Dispos. 2019 Feb;47(2):94-103
pubmed: 30504137
Drug Metab Dispos. 2004 Nov;32(11):1247-53
pubmed: 15286053

Auteurs

Hyun-Moon Back (HM)

Department of Pharmaceutics, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, New Jersey, USA.

Hwi-Yeol Yun (HY)

College of Pharmacy, Chungnam National University, Daejeon, Republic of Korea.

Sang Kyum Kim (SK)

College of Pharmacy, Chungnam National University, Daejeon, Republic of Korea.

Jae Kyoung Kim (JK)

Department of Mathematical Sciences, Korean Advanced Institute of Science and Technology, Daejeon, Republic of Korea.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH